Austin, May 22, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, the global Exosomes Market size was valued at USD 136.16 million in 2023 and is expected to reach USD 1,311.03 million by 2032, exhibiting a CAGR of 28.62 % during the forecast period of 2024-2032.
Exosomes Market Growth Analysis
- Increased Funding for Exosome R&D: Significant investment from the public and private sector, including funding by the National Institutes of Health (NIH) and venture capital firms, is accelerating the development of exosome-based diagnostics and therapeutic applications.
- Technology Advancements: Enhanced exosome extraction kits, micro systems, and AI-supported analysis software have made the application of EVs more accurate and scalable.
- Clinical Implications in Oncology and Neurology: Exosomes are gaining clinical importance as non-invasive markers of disease and drug delivery vehicle, in cancer and neurodegeneration in particular.
- AI Integration: With exosomes related to exosome characterization, machine learning and other AI tools can be used to improve the characterization of exosomes providing much more targeted, predictive diagnostics.
Get a Sample Report of Exosomes Market@ https://www.snsinsider.com/sample-request/4091
US Exosomes Market Outlook
The United States Exosomes market was valued at $41.77 million in 2023 and is expected to reach $399.74 million by 2032, registering a CAGR of 28.53 %. Enablers of this growth include:
- Strong support from the likes of NIH and FDA
- Leading players such as Thermo Fisher Scientific and Codiak BioSciences pioneering exosome isolation and therapeutic platforms
- Collaborations for advancing clinical adoption between academia and industry have strengthened
Major Players Analysis Listed in this Report are:
- Aethlon Medical, Inc. (Aethlon Hemopurifier, Exosome Enrichment Kits)
- Anjarium Biosciences AG (Anjarium Exosome Therapeutic Platform, Anjarium Exosome Isolation)
- Bio-Techne Corporation (Exosome Isolation Kits, Exosome ELISA Kits)
- Clara Biotech (ExoQuick, Exosome Purification Kits)
- Codiak BioSciences (Engex Exosome Platform, Exosome-based Immunotherapy)
- Creative Biolabs (Exosome Isolation Kits, Custom Exosome Production Service)
- Everzom (Exosome-based Drug Delivery, Exosome Isolation Kits)
- Exopharm (Exosome-based Delivery Platform, Exosome Isolation and Characterization Kits)
- Fujifilm Holdings Corporation (Exosome Isolation Kits, Exosome Storage Solutions)
- ILIAS Biologics, Inc. (ILIAS Exosome-Based Drug Delivery Platform, Exosome Engineering Services)
- INOVIQ (Exosome Detection Kits, ExoTEST for Cancer Diagnostics)
- Lonza (Exosome Isolation Kit, Lonza Exosome Culture Media)
- Miltenyi Biotec (MACS Exosome Isolation Kits, Exosome Characterization Tools)
- Norgen Biotek Corp. (Exosome RNA Isolation Kit, Exosome Isolation Reagent)
- QIAGEN (QIAprep Exosome Kit, QIAzol Lysis Reagent for Exosome RNA)
- Rion, Inc. (Exosome Purification Kit, Exosome-based Regenerative Solutions)
- RoosterBio, Inc. (Exosome Isolation Kits, MSC-derived Exosome Products)
- Thermo Fisher Scientific, Inc. (ExoEasy Exosome Isolation Kit, Thermo Scientific Exosome Analysis Kits)
- Unchained Labs (ExoTag Exosome Isolation Kit, ExoView Exosome Characterization System)
- Danaher Corporation (Beckman Coulter) (Cytomics FC500 Flow Cytometer, Exosome Isolation Kits)
Exosomes Market Report Scope
| Report Attributes | Details |
| Market Size in 2023 | US$ 136.16 million |
| Market Size by 2032 | US$ 1,311.03 million |
| CAGR | CAGR of 28.62% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Key Regional Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East]), Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
Segment Analysis
By Product:
In 2023, Kits & Reagents held the largest share of the product market (55%), a reflection of the irreplaceable nature of this category in exosome research. They are important tools for exosome separation and detection in laboratory research, especially in the research of cancer biomarkers and drug screening. These methods became popular mainly due to their simplicity, reproducibility, and applications on common analytical instruments. The fastest growth is in the Instruments segment, which is benefiting from new microfluidics, nanoparticle tracking, and flow cytometry technology.
By Indication:
Cancer was the leading indication in 2023, representing 40.5% of the market. Exosomes offer a non-invasive means to detect tumor-specific biomarkers, enabling early diagnosis, monitoring of therapeutic response, and development of targeted treatments. Exosomes derived from tumor cells provide a snapshot of tumor biology, allowing for real-time disease surveillance across cancers such as breast, lung, colorectal, and prostate. Meanwhile, Neurological Disorders are emerging as the fastest-growing segment. Exosomes' ability to cross the blood-brain barrier makes them ideal candidates for diagnosing neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Their potential to reveal CNS-specific changes through blood samples addresses a significant gap in neurology diagnostics.
By Application:
Biomarkers accounted for 48.7% of the market in 2023. The ability of exosomes to carry clinically relevant biomolecules such as miRNAs, proteins, and lipids has driven their adoption in disease monitoring. Diagnostic companies are increasingly investing in exosome-derived biomarker panels to enhance the sensitivity and specificity of disease detection. In parallel, Drug Delivery is the fastest-growing application, driven by the pursuit of biocompatible and targeted delivery vehicles. Engineered exosomes are being explored for carrying therapeutic payloads like siRNA, mRNA, and chemotherapeutics, reducing systemic toxicity and improving therapeutic outcomes.
By End User:
Pharmaceutical & Biotechnology Companies held a commanding 55.2% market share in 2023, reflecting their leadership in exosome therapeutics and diagnostics development. These firms are leveraging exosomes in R&D workflows and forming alliances to co-develop cutting-edge platforms. On the other hand, Academic & Research Institutes represent the fastest-growing segment. With increased funding and government backing, universities are playing a critical role in innovating isolation techniques and expanding the understanding of exosome biology, which is instrumental in driving clinical translation.
Buy a Single-User PDF of Exosomes Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/4091
Exosomes Market Segmentation
By Product
- Kits & Reagents
- Instruments
- Services
By Indication
- Cancer
- Neurodegenerative diseases
- Cardiovascular diseases
- Infectious diseases
- Others
By Application
- Biomarkers
- Vaccine Development
- Tissue Regeneration
- Others
By End User
- Pharmaceutical & biotechnology companies
- Hospitals & diagnostics centers
- Academic & research institutes
Regional Analysis
North America accounted for 41.7% of global revenue in 2023, led by the United States. The region benefits from a highly developed healthcare infrastructure, extensive R&D activity, and a strong network of biopharma companies. High funding levels, a growing clinical trials pipeline, and early adoption of precision medicine technologies are fueling market dominance. The collaborative ecosystem involving academia, industry, and government is accelerating product development and commercialization.
Meanwhile, Asia Pacific is expected to be the fastest-growing region, driven by rising investments in regenerative medicine, expanding biotech industries, and supportive regulatory reforms in countries like China, India, Japan, and South Korea. Local companies are increasingly investing in in-house R&D and entering licensing deals to integrate exosome technologies into their therapeutic pipelines. Academic institutions in the region are also producing high-impact research, setting the stage for future clinical and commercial expansion.
Recent Developments
- March 2024: Evox Therapeutics shared promising preclinical results for an exosome-based treatment for rare metabolic disorders.
- February 2024: Aethlon Medical launched early-phase human trials for its Hemopurifier device targeting cancer-related exosomes.
- January 2024: Codiak BioSciences reprioritized its pipeline to focus on oncology exosome therapeutics after positive Phase I outcomes.
- Top of Form
- Bottom of Form
Need Any Customization Research on Exosomes Market, Enquire Now@ https://www.snsinsider.com/enquiry/4091
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
5.1 Exosome Isolation Techniques
5.2 Technological Advancements in Exosome Research
5.3 Clinical Trials and Research Studies
5.4 Impact of Artificial Intelligence on Exosome Research
5.5 Investment and Funding Trends
6. Competitive Landscape
7. Exosomes Market by Product
8. Exosomes Market by Indication
9. Exosomes Market by Application
10. Exosomes Market by End User
11. Regional Analysis
12. Company Profiles
13. Use Cases and Best Practices
14. Conclusion
Related Reports
Liquid Biopsy Market Set to Triple by 2032, Surging to $21.78 Billion at 13.11% CAGR
Nanomedicine Market to Reach $634.2 Billion by 2032, Growing Steadily at 12.2% CAGR
Exosome Diagnostics & Therapeutics Market to Skyrocket from $36M to $2.96B by 2032 at 63.25% CAGR
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
